Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemoimmunotherapy for canine lymphosarcoma.

S E Crow, G H Theilen, E Benjaminini

    Cancer
    |November 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques.

    Clinical immunology (Orlando, Fla.)·2001
    Same author

    Application of immunologic methods in clinical trials.

    Toxicology·1998
    Same author

    Effect of food on the relative bioavailability of oral ganciclovir.

    Journal of clinical pharmacology·1996
    Same author

    Oral ganciclovir for cytomegalovirus infections.

    Advances in experimental medicine and biology·1996
    Same author

    Clinical trials in veterinary oncology: a clinician's viewpoint.

    The Veterinary clinics of North America. Small animal practice·1996
    Same author

    Concurrent renal adenocarcinoma and polycythemia in a dog.

    Journal of the American Animal Hospital Association·1995
    Same journal

    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

    Cancer·2026
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    See all related articles

    This study found that adding a tumor cell extract vaccine to chemotherapy significantly improved remission and survival times in dogs with multicentric lymphosarcoma, suggesting immunotherapy benefits cancer treatment.

    Area of Science:

    • Veterinary Oncology
    • Immunotherapy
    • Cancer Research

    Background:

    • Multicentric lymphosarcoma is a common cancer in dogs.
    • Conventional chemotherapy offers limited long-term survival for canine lymphosarcoma.
    • The role of immunotherapy as an adjunct to chemotherapy requires further investigation.

    Purpose of the Study:

    • To evaluate the efficacy of a chemically-modified tumor cell extract vaccine combined with chemotherapy in dogs with multicentric lymphosarcoma.
    • To assess the impact of this combined treatment on remission duration and overall survival.

    Main Methods:

    • Thirty-two dogs with naturally occurring multicentric lymphosarcoma were randomized into two groups.
    • One group received standard combination chemotherapy with vitamin injections (controls).

    Related Experiment Videos

  • The other group received identical chemotherapy plus a tumor cell extract vaccine in Freund's complete adjuvant (vaccinates).

    • Main Results:

    • No significant difference in clinical staging or initial disease severity between groups.
    • Twenty dogs (62%) showed a favorable response to chemotherapy.
    • Vaccinated dogs demonstrated significantly longer first remission duration and total survival times compared to controls.

    Conclusions:

    • Immunological stimulation using a tumor cell extract vaccine may be a beneficial adjunct to conventional chemotherapy for canine multicentric lymphosarcoma.
    • Adherence to immunological principles is crucial for successful immunotherapy in cancer treatment.
    • This study supports the potential of immunotherapy in veterinary oncology.